Recruiting Bevacizumab Combined With Cisplatin Versus Cisplatin Monotherapy in Malignant Serous Effusions NCT07090525 Conditions Overall Response Rate Locations Qingdao Central Hospital — Qingdao, Shandong, China View Trial Details
Recruiting Precision Radiotherapy for Tumours Using Magnetic Resonance-guided Linear Accelerator (MR-Linac) NCT06531681 Conditions Neoplasms, Oncology, Overall Response Rate, +4 more Locations The Second Affiliated Hospital of Hainan Medical University — Haikou, China View Trial Details
Recruiting A Study on the Safety and Efficacy of the Combination of Candenizumab, Lenvatinib, and SOX Regimen in the Treatment of HER2 Negative Advanced Gastric or Gastroesophageal Junction Adenocarcinoma Patients NCT06277024 Conditions Digestive System Diseases, Digestive System Neoplasms, Gastrointestinal Diseases, +6 more Locations Department of Gastric Surgery， Fujian Medical University Union Hospital — Fuzhou, Fujian, China View Trial Details
Completed Study for HER2-Overexpressed MBC Patients Treated by Cipterbin® Plus vinorelbinE NCT01291667 Conditions Adverse Events, Overall Response Rate, Progress-free Survival Locations Not specified View Trial Details
